{
  "trial_id": "NCT02742051",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "signed written informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "non-metastatic unilateral invasive ER-positive, HER2-negative breast cancer with a primary breast tumor > 2cm by imaging or an axillary lymph node > 2cm by imaging",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "postmenopausal women with age less than 70 years old",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "no history of hormone therapy, chemotherapy, breast cancer surgery and radiotherapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "normal cardiac functions by echocardiography",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ECOG scores are \u22642",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "can swallow pills",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hb\u226590g/L",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "WBC\u22654E+9/L",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Plt\u2265100E+9/L",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Neutrophils\u22651.5E+9/L",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ALT and AST \u2264 triple of normal upper limit",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "TBIL \u2264 1.5 times of normal upper limit",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "other cancers at the same time or have the history of other cancers except controlled skin basal cell carcinoma or skin squamous cell carcinoma or carcinoma in situ of cervix uterus",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "active infections that were not suitable for chemotherapy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "severe non-cancerous diseases",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "bilateral breast cancers or multifocal breast cancers or inflammatory breast cancers",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "history of previous treatment with mTOR inhibitors",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "current administration of anti-cancer therapies, or attending other clinical trials",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "special conditions that they cannot understand the written informed consent, such as they are demented or hawkish",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "allergic history or contraindication of any of the interventional drugs",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer. A core biopsy revealed a 3 cm invasive ductal breast carcinoma in the left upper outer quadrant.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT02742051",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}